|Global trends in molecular epidemiology of HIV-1 during 2000–2007|
J Hemelaar, E Gouws, PD Ghys, S Osmanov
AIDS (London, England) 25 (5), 679, 2011
|Transmission of drug-resistant HIV-1 is stabilizing in Europe|
J Vercauteren, AMJ Wensing, DAMC van de Vijver, J Albert, C Balotta, ...
The Journal of infectious diseases 200 (10), 1503-1508, 2009
|HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics|
AB Abecasis, AMJ Wensing, D Paraskevis, J Vercauteren, K Theys, ...
Retrovirology 10 (1), 1-13, 2013
|Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe|
LM Hofstra, N Sauvageot, J Albert, I Alexiev, F Garcia, D Struck, ...
Clinical infectious diseases 62 (5), 655-663, 2016
|Relating increasing hantavirus incidences to the changing climate: the mast connection|
J Clement, J Vercauteren, WW Verstraeten, G Ducoffre, JM Barrios, ...
International Journal of Health Geographics 8 (1), 1-11, 2009
|Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials|
JT Maringwa, C Quinten, M King, J Ringash, D Osoba, C Coens, ...
Supportive Care in Cancer 19 (11), 1753-1760, 2011
|Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis|
J Hemelaar, R Elangovan, J Yun, L Dickson-Tetteh, I Fleminger, S Kirtley, ...
The Lancet infectious diseases 19 (2), 143-155, 2019
|Algorithms for the interpretation of HIV-1 genotypic drug resistance information|
J Vercauteren, AM Vandamme
Antiviral research 71 (2-3), 335-342, 2006
|Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings|
RZ Sangeda, F Mosha, M Prosperi, S Aboud, J Vercauteren, RJ Camacho, ...
BMC public health 14 (1), 1-11, 2014
|Primary resistance to integrase strand-transfer inhibitors in Europe|
M Casadellŕ, PM Van Ham, M Noguera-Julian, A Van Kessel, C Pou, ...
Journal of Antimicrobial Chemotherapy 70 (10), 2885-2888, 2015
|Investigation of expert rule bases, logistic regression, and non-linear machine learning techniques for predicting response to antiretroviral treatment|
MCF Prosperi, A Altmann, M Rosen-Zvi, E Aharoni, G Borgulya, F Bazso, ...
Antivir Ther 14 (3), 433-42, 2009
|CRF19_cpx is an evolutionary fit HIV-1 variant strongly associated with rapid progression to AIDS in Cuba|
V Kouri, R Khouri, Y Alemán, Y Abrahantes, J Vercauteren, ...
EBioMedicine 2 (3), 244-254, 2015
|Gender differences in HIV disease progression and treatment outcomes among HIV patients one year after starting antiretroviral treatment (ART) in Dar es Salaam, Tanzania|
F Mosha, V Muchunguzi, M Matee, RZ Sangeda, J Vercauteren, ...
BMC public health 13 (1), 1-7, 2013
|The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001–2006) in Portugal|
J Vercauteren, K Deforche, K Theys, M Debruyne, LM Duque, S Peres, ...
Retrovirology 5 (1), 1-8, 2008
|Transmission of drug-resistant HIV-1 in Europe remains limited to single classes|
AMJ Wensing, J Vercauteren, DA van de Vijver, J Albert, B Asjo, C Balotta, ...
Aids 22 (5), 625-635, 2008
|Higher proportion of G2P  rotaviruses in vaccinated hospitalized cases compared with unvaccinated hospitalized cases, despite high vaccine effectiveness against heterotypic …|
J Matthijnssens, M Zeller, E Heylen, S De Coster, J Vercauteren, ...
Clinical Microbiology and Infection 20 (10), O702-O710, 2014
|Global dispersal pattern of HIV type 1 subtype CRF01_AE: a genetic trace of human mobility related to heterosexual sexual activities centralized in Southeast Asia|
K Angelis, J Albert, I Mamais, G Magiorkinis, A Hatzakis, O Hamouda, ...
The Journal of infectious diseases 211 (11), 1735-1744, 2015
|The global spread of HIV-1 subtype B epidemic|
G Magiorkinis, K Angelis, I Mamais, A Katzourakis, A Hatzakis, J Albert, ...
Infection, genetics and evolution 46, 169-179, 2016
|Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe|
D Frentz, DAMC Van de Vijver, AB Abecasis, J Albert, O Hamouda, ...
BMC infectious diseases 14 (1), 1-12, 2014
|Patterns of transmitted HIV drug resistance in Europe vary by risk group|
D Frentz, D van de Vijver, A Abecasis, J Albert, O Hamouda, L Jřrgensen, ...
PloS one 9 (4), e94495, 2014